ODI Pharma AB (publ), a pharmaceutical company, produces and distributes pharmaceutical cannabis and cosmetics products in Europe. The company offers cannabidiol-infused facial cream, facial mask, and body balm under the Kandol. brand name through kandol.net. The company was founded in 2018 and is based in Stockholm, Sweden.
Stock data | 2023 | Change |
---|---|---|
Price | $0.4734911637212404 | N/A |
Market Cap | $7.26M | N/A |
Shares Outstanding | 15.34M | 1.69% |
Employees | 1.00 | N/A |
Shareholder Equity | 2.57M | -72.22% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -1.05 | N/A |
P/S Ratio | 531.55 | N/A |
P/B Ratio | 2.82 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.2628 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $13.66K | N/A |
Earnings | -$676.02K | N/A |
EPS | -0.45 | N/A |
Earnings Yield | -0.9504 | N/A |
Gross Margin | -5.15 | N/A |
Operating Margin | -48.84 | N/A |
Net income margin | -49.49 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $801.84K | N/A |
Cash on Hand | $636.02K | N/A |
Debt to Equity | 0.2137 | 1535.26% |
Current Ratio | $1.46 | -82.83% |